市场调查报告书
商品编码
1433422
全球医药塑胶包装市场2023-2030Global Pharmaceutical Plastic Packaging Market 2023-2030 |
预计全球药用塑胶包装市场在预测期内将以 6.0% 的CAGR成长。製药业的不断发展以及製药业对塑胶包装因其所提供的优势的高需求是推动全球製药塑胶包装市场成长的关键因素。塑胶与泡罩、瓶子、层压板等任何形式的相容性也使其在药品包装中的使用越来越受欢迎。展望该行业的成长,主要参与者正在采取重大倡议,以增加其在全球市场的影响力。
例如,2023年3月,Alpla集团与西班牙包装公司Inden Pharma成立了一家合资企业,以扩大在药品包装市场的份额。该合资企业将利用 ALPLApharma 在希腊和波兰的生产基地以及 Inden Pharma 在西班牙的两个工厂。 Alpla Group 和 Inden Pharma 也将在德国马克多夫建立一座工厂。这些工厂今年将总共生产约8亿件药品包装产品。合作伙伴计划在五年内将产能提高 300.0%。然而,由于塑胶对环境产生有害影响,对其实施严格的法规可能会限制全球市场的成长。用于包装的药用塑胶瓶由防儿童开启的瓶盖和封口组成。儿童安全包装和无污染药物输送预计将扩大药品市场塑胶瓶和容器销售的成长机会,推动全球市场。
Global Pharmaceutical Plastic Packaging Market Size, Share & Trends Analysis Report by Raw Material (Polypropylene (PP), Polyethylene Terephthalate (PET), Low Density Polyethylene (LDPE), High Density Polyethylene (HDPE), and Others), by Product Type (Solid Containers, Dropper bottles, Nasal Spray Bottles, Liquid Bottles, Oral Care, Pouches, Vials, and Ampoules, Cartridges, Syringes, and Others) Forecast Period (2024-2031)
The global pharmaceutical plastic packaging market is anticipated to grow at a considerable CAGR of 6.0% during the forecast period. The growing pharmaceutical industry and high demand for plastic packaging in the pharmaceutical industry owing to its offered advantages is a key factor driving the growth of the global pharmaceutical plastic packaging market. The compatibility of plastic with any form such as blister, bottles, laminates, and others is also increasing its popularity to be used in pharmaceutical packaging. Looking towards the growth aspect of this industry, key players are making significant moves to increase their presence in the global market.
For instance, in March 2023, Alpla Group formed a joint venture with Spanish packaging company Inden Pharma to expand its presence in the pharmaceutical packaging market. The JV will make use of ALPLApharma's production sites in Greece and Poland, as well as Inden Pharma's two facilities in Spain. Alpla Group and Inden Pharma will also build a facility in Markdorf, Germany. These facilities will produce around 800 million pharmaceutical packaging products in total this year. The partners plan to increase their capacity by 300.0% over five years. However, the presence of stringent regulations regarding plastic owing to its harmful impact on the environment may restrain the growth of the global market. Pharmaceutical plastic bottles used for packaging consist of child-resistant caps and closures. Child-safe packaging and contamination-free drug delivery are expected to amplify growth opportunities in sales of plastic bottles and containers for the pharmaceuticals market, thereby driving the global market.
The global pharmaceutical plastic packaging market is segmented based on raw materials and product type. Based on raw material, the market is segmented into Polypropylene (PP), Polyethylene Terephthalate (PET), Low-Density Polyethylene (LDPE), High Density Polyethylene (HDPE), and other (COP). Based on product type, the market is segmented into solid containers, dropper bottles, nasal spray bottles, liquid bottles, oral care, pouches, vials and ampoules, cartridges, syringes, and others (caps and closures).
PET held a considerable share in 2023 based on raw materials. The high demand for PET in pharma packaging owing to its offered advantages is a key factor driving the growth of this market segment. The development of advanced recyclable PET is further contributing to the segmental market growth. For instance, in January 2024, TekniPlex Healthcare partnered with petrochemical provider Alpek Polyester to introduce a pharmaceutical-grade polyethylene terephthalate (PET) blister film containing significant recycled content. This film is suitable for a wide array of primary packaging applications, with 30% of its PET polymerized from PCR-origin through chemical recycling.
The global pharmaceutical plastic packaging market is further segmented based on geography, including North America (the US and Canada), Europe (Italy, Spain, Germany, France, and others), Asia-Pacific (India, China, Japan, South Korea, and others), and the Rest of the World (the Middle East & Africa and Latin America). Among these, the North American regional market is expected to cater to considerable growth during the forecast period. Factors contributing to the regional growth of the market include the use of advanced technology such as nanotechnology in manufacturing processes and technological innovation and increasing demand for drug delivery devices. North America is followed by Europe while Asia-Pacific is expected to be the fastest-growing market during the forecast period.
Factors such as the increasing popularity of rigid plastic material and the high demand for Polyethylene Terephthalate (PET) and Polyethylene (PE) as the primary plastics will also contribute to the growth of pharmaceutical packaging in the region. China is a major economy in the region which contributes majorly to the market's growth. India and Japan are also contributing significantly to the market.
The major companies serving the global pharmaceutical plastic packaging market include Gerresheimer AG, Amcor Ltd., Berry Plastics Group, Inc., Aptar Group Inc., and O. Berk Company LLC among others. The market players are considerably contributing to the market growth by the adoption of various strategies, including mergers and acquisitions, partnerships, collaborations, production capacity expansion, and technological advancement among others to stay competitive in the market. For instance, in May 2022, Gerresheimer significantly ramped up its glass and plastic production capacities in India with new facilities and capabilities. The enhancement of Gerresheimer's local production and sales footprint in Emerging Markets is part of the company's regional expansion plans.